Elicio Therapeutics, Inc. (ELTX) has 11 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 2, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 2, 2026 filed Aug. 31, 2026 | ADAMS JULIAN Director | $0 | 21,750 | 0% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | Ashe Carol Gail Director | $0 | 21,750 | 0% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | Nissenson Allen Director | $0 | 21,750 | 0% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | Chudnovsky Yekaterina Director | $0 | 21,750 | 0% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | RUFFOLO ROBERT R Director | $0 | 21,750 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 11 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free